Share on StockTwits

Research analysts at M Partners assumed coverage on shares of Aurinia Pharmaceuticals (TSXVENTURE:AUP) in a report released on Wednesday, AR Network reports. The firm set a “buy” rating on the stock.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.